Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Mebutamate

Mebutamate

Mebutamate structure

Mebutamate 

structure
  • CAS No:

    64-55-1

  • Formula:

    C10H20N2O4

  • Chemical Name:

    Mebutamate

  • Synonyms:

    1,3-Propanediol,2-methyl-2-(1-methylpropyl)-,1,3-dicarbamate;1,3-Propanediol,2-sec-butyl-2-methyl-,dicarbamate;1,3-Propanediol,2-methyl-2-(1-methylpropyl)-,dicarbamate;Carbamic acid,2-sec-butyl-2-methyltrimethylene ester;W 583;Axiten;2-sec-Butyl-2-methyl-1,3-propanediyl dicarbamate;2-sec-Butyl-2-methyltrimethylene dicarbamate;Capla;2,2-Dicarbamyloxymethyl-3-methylpentane;Mebutamate;Vallene;Mebutamat;Mebutina;Mioartrina;No-Press;Carbuten;Encapla;Preminex;Sigmafon;Mega;Butatensin;Dicamoylmethane;Prean;Dormate;Ipotensivo;NSC 163921;2-Methyl-2-(1-methylpropyl)-1,3-propanediol Dicarbamate

Description

Mebutamate is an organic molecular entity.|Mebutamate is a DEA Schedule IV controlled substance. Substances in the DEA Schedule IV have a low potential for abuse relative to substances in Schedule III.|Mebutamate is a sedative and anxiolytic drug with anti-hypertensive (blood pressure lowering) effects comparable to those of other barbiturates but is only around 1/3rd the potency of secobarbital as a sedative. Side effects include dizziness and headaches.

Mebutamate Basic Attributes

232.27700

232.28

200-587-5

2800

163921

DTXSID1023239

N - Nervous system

2924199090

Characteristics

104.64000

2.63000

1.114g/cm3

77 °C

435ºC at 760 mmHg

216.8ºC

1.477

1000 mg/L

LD50 oral in rat: 1160mg/kg

Safety Information

36/37/38

S26;S36/S37/S39

P264, P270, P301+P312, P330, P501

H302

|Warning|H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]|P264, P270, P301+P312, P330, and P501|The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

Drug Information

Mebutamate|Capla|2800|Schedule IV - Substances in the DEA Schedule IV have a low potential for abuse relative to substances in Schedule III.|No

Mebutamate Use and Manufacturing

Uses

Antihypertensive.

Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients

Computed Properties

Molecular Weight:232.28
XLogP3:1.4
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:4
Rotatable Bond Count:8
Exact Mass:232.14230712
Monoisotopic Mass:232.14230712
Topological Polar Surface Area:105
Heavy Atom Count:16
Complexity:237
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.